3D printed hydrogels to be used in cancer immunotherapy

The new 3D hydrogels provide high rates of cell proliferation, as they mimic lymph nodes, where T-cells reproduce in vivo. A new project, led by researchers from ICMAB and IBEC, and with the collaboration of VHIO and UIC, wants to transfer this technology to hospitals.

Photo
Initial prototype of a hydrogel scaffold manufactured with a 3D printer.
Source: ICMAB-CSIC; IBEC.

A team with the participation of researchers from the ICMAB has designed new hydrogels that allow the culture of T-cells or T-lymphocytes, cells of the immune system that are used in cancer immunotherapy since they have the capacity to destroy tumor cells. These hydrogels can mimic lymph nodes, where T-cells reproduce and, therefore, provide high rates of cell proliferation. Scientists hope to be able to bring this new technology, for which a patent has already been filed at the European Patent Office, to hospitals soon. Scientists have started a project that aims to print these new hydrogels in 3D and thus accelerate their transfer to the market.

The 3D hydrogels are made of polyethylene glycol (PEG), a biocompatible polymer widely used in biomedicine, and heparin, an anticoagulant agent. In this case, the polymer provides the structure and mechanical properties necessary for T-cells to grow, while heparin is used to anchor different biomolecules of interest, such as cytokine CCL21, a protein present in the lymph nodes and which has a major role in cell migration and proliferation.

Adoptive cell therapy

Cancer immunotherapy is based on using and strengthening the patients' immune system so that it recognizes and fights tumor cells, without damaging healthy tissues. One of the possible treatments, the so-called adoptive cell therapy, consists of extracting the T-cells from the patients, modifying them to make them more active, making numerous copies of them and injecting them back into patients.

"This personalized therapy, although still very novel, seems to have more lasting effects than current oncological therapies, thanks to some T-lymphocytes that are capable of conferring immunity over time," points out one of the creators of this technology, researcher Judith Guasch, from the Institute of Materials Science of Barcelona (ICMAB-CSIC). "Its application is limited by the current cell culture media, since they are not effective enough for the proliferation and growth of a relevant amount of therapeutic T-cells in a short time and in an economically viable way", adds Guasch.

Transfer to the market

Photo
Simplified diagram showing the process of adoptive cell therapy: extraction of cells, expansion and differentiation, and injection of cells into patients
Source: Biomaterials (259, 120313, 2020)

To continue the study and encourage the transfer of this technology to the market, researchers Judith Guasch, from the ICMAB, and Elisabeth Engel, professor at the Polytechnic University of Catalonia (UPC) at the Institute of Bioengineering of Catalonia (IBEC), have recently been awarded a project from the Call for Transfer and Valorization Projects of the Biomedical Research Networking Center - Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN) 2020, aimed at carrying out projects for CIBER-BBN groups with the interest and support of companies.

The aim of the project is to print large 3D hydrogels compatible with clinical bioreactors, in order to expand T-cells in a more efficient way. The researchers will develop the prototype in the laboratory and make the first experiments for the validation in the clinical phase. Currently, the project is looking for industrial partners, mainly biomedical and pharmaceutical companies, and investors interested in creating a spin-off company to transfer this technology and make it available in hospitals.

The details are published in the journal Biomaterials.

Subscribe to our newsletter

Related articles

Microneedles for painless drug delivery

Microneedles for painless drug delivery

Researchers suggest using microneedles for immunotherapy due to the high abundance of immune cells under the skin. The aim is to vaccinate or treat different diseases with minimal invasiveness.

Researchers use bioprinting to create nose cartilage

Researchers use bioprinting to create nose cartilage

Researchers have used 3D bioprinting technology to create custom-shaped cartilage. They aim to make it easier for surgeons to safely restore the features of skin cancer patients living with nasal cartilage defects after surgery.

Radiation therapy: 3D printed shields for protection

Radiation therapy: 3D printed shields for protection

To reduce tissue injury side effects from radiation therapy, researchers have developed 3D-printed gastrointestinal radioprotective devices that can be generated from patient CT scans.

3D printed oesophageal stents to revolutionize cancer treatment

3D printed oesophageal stents to revolutionize cancer treatment

World-first 3D printed oesophageal stents developed by the University of South Australia could revolutionize the delivery of chemotherapy drugs.

Smart plaster for healing chronic wounds

Smart plaster for healing chronic wounds

Researchers have developed gel patches from a 3D printer that can be activated individually.

Insulin-producing implant for diabetics

Insulin-producing implant for diabetics

Bioengineers are using 3D printing and smart biomaterials to create an insulin-producing implant for type 1 diabetes patients.

Immunotherapy response studied in body-on-a-chip models

Immunotherapy response studied in body-on-a-chip models

Clinicians are using patient-specific tumor 'organoid' models as a preclinical companion platform to better evaluate immunotherapy treatment for appendiceal cancer.

Quantum physics helps destroy cancer cells

Quantum physics helps destroy cancer cells

Researchers have found a way to enhance radiation therapy using novel iodine nanoparticles.

Hydrogel protects against resistant bacteria

Hydrogel protects against resistant bacteria

Researchers have developed a specially designed hydrogel that works against all types of bacteria, including antibiotic-resistant ones.

Popular articles

Subscribe to Newsletter